TrialPsychopharmacology2021

Relative potency of intravenous oxymorphone compared to other µ opioid agonists in humans - pilot study outcomes.

Shanna Babalonis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.